Related Experiment Video
Updated: Jan 23, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
Multidrug-resistant Shigella infection in pediatric patients with diarrhea from central Iran
Elnaz Abbasi1,2, Hamid Abtahi3, Alex van Belkum4
1Department of Microbiology & Immunology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.
Insights
This study found high rates of antibiotic resistance in Shigella species causing pediatric diarrhea in Iran. Resistance to common antibiotics like cotrimoxazole and third-generation cephalosporins is a significant concern for treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Shigella species are a leading cause of pediatric diarrhea globally.
- Increasing antibiotic resistance, particularly to fluoroquinolones and third-generation cephalosporins, complicates shigellosis management.
- This study investigated Shigella prevalence and resistance patterns in central Iran.
Purpose of the Study:
- To determine the prevalence of Shigella species in pediatric diarrhea cases in central Iran.
- To characterize the antibiotic resistance patterns of isolated Shigella strains.
- To identify the presence of specific resistance genes, including ESBL and AmpC.
Main Methods:
- Pediatric diarrhea samples (n=230) were analyzed using bacterial culture and genus-specific PCR (ipaH).
- Antibiotic susceptibility testing was performed on Shigella isolates.
- Phenotypic and genotypic analysis for Extended-Spectrum Beta-Lactamase (ESBL) and AmpC resistance was conducted.
Main Results:
- Shigella was detected in 11.3% of samples by PCR, with Shigella sonnei and Shigella flexneri being most common.
- High resistance rates were observed for cotrimoxazole (100%), ampicillin (84.2%), cefixime (68.4%), and ceftriaxone (63.1%).
- ESBL genes (blaTEM, blaCTX-M-1, blaCTX-M-15) and AmpC genes (blaCMY-2) were frequently detected. Resistance to ciprofloxacin was also noted.
Conclusions:
- A significant prevalence of Shigella with high levels of antibiotic resistance was found in pediatric patients.
- Resistance to third-generation cephalosporins (ESBL producers) and fluoroquinolones like ciprofloxacin is a serious public health concern.
- Effective treatment strategies for pediatric shigellosis require careful consideration of local antibiotic resistance data.
Abstract:
Background: Shigella spp. are primary pathogens of diarrhea in children worldwide. Emergence of resistance to fluoroquinolones and third-generation cephalosporins is crucial in the management of pediatric shigellosis. We determined the prevalence and the antibiotic resistance patterns of Shigella species isolated from pediatric patients in central Iran. Materials and methods: Pediatric diarrhea samples (n=230) were cultured on MacConkey and XLD agar media and in GN broth. Genus-specific PCR for ipaH was also used for detection directly from fecal specimens. Antibiotic resistance and the frequency of ESBL and AmpC genes were determined. Results: Out of the 230 samples, 19 (8.2%) cases of Shigella spp. were identified using culture. Twenty-six samples were positive by PCR (11.3%), S. flexneri (4/19; 21%) and S. sonnei (15/19; 78.9%) being the most detected. The highest antibiotic resistance rates were found for cotrimoxazole (19/19; 100%), ampicillin (16/19; 84.2%), cefixime (13/19; 68.4%) and ceftriaxone (12/19; 63.1%). Ten cases showed phenotypic ESBL presence and all these strains were positive for bla TEM, bla CTX-M-1, and bla CTX-M-15. Three strains were AmpC positive, all of which harbored bla CMY-2 and two contained bla CIT. Of the 19 Shigella isolates 5 (26.3%), 2 (10.5%), and 1 (5.2%) were phenotypically resistant to nalidixic acid, ciprofloxacin, and norfloxacin, respectively. Class 1 integron was found in 18 (94.7%) isolates whereas class 2 integron was found in 19 (100%) strains. Conclusion: We found a considerable presence of Shigella species with elevated antibiotic resistance levels. In particular, the resistance to third-generation cephalosporins (ESBL) and ciprofloxacin must be taken seriously.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
The Central Dogma

